Erratum: Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592))

Qian Li; Mei Liu; Fei Ma; Yang Luo; Ruigang Cai; Liming Wang; Ningzhi Xu; Binghe Xu

doi:10.1371/journal.pone.0136826

Erratum: Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592))

Qian Li
, Mei Liu
, Fei Ma
, Yang Luo
, Ruigang Cai
, Liming Wang
, Ningzhi Xu
, Binghe Xu

Health Science Center

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Article number	e0136826
Journal	PLoS ONE
Volume	10
Issue number	8
DOIs	https://doi.org/10.1371/journal.pone.0136826
State	Published - 25 Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1371/journal.pone.0136826

Cite this

Li, Q., Liu, M., Ma, F., Luo, Y., Cai, R., Wang, L., Xu, N., & Xu, B. (2015). Erratum: Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592)). PLoS ONE, 10(8), Article e0136826. https://doi.org/10.1371/journal.pone.0136826

@article{6af1dc36f6bd4802aeb04281a2bf7adc,

title = "Erratum: Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592))",

author = "Qian Li and Mei Liu and Fei Ma and Yang Luo and Ruigang Cai and Liming Wang and Ningzhi Xu and Binghe Xu",

year = "2015",

month = aug,

day = "25",

doi = "10.1371/journal.pone.0136826",

language = "英语",

volume = "10",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "8",

}

TY - JOUR

T1 - Erratum

T2 - Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592))

AU - Li, Qian

AU - Liu, Mei

AU - Ma, Fei

AU - Luo, Yang

AU - Cai, Ruigang

AU - Wang, Liming

AU - Xu, Ningzhi

AU - Xu, Binghe

PY - 2015/8/25

Y1 - 2015/8/25

UR - https://www.scopus.com/pages/publications/84942891435

U2 - 10.1371/journal.pone.0136826

DO - 10.1371/journal.pone.0136826

M3 - 评论/辩论

AN - SCOPUS:84942891435

SN - 1932-6203

VL - 10

JO - PLoS ONE

JF - PLoS ONE

IS - 8

M1 - e0136826

ER -

Erratum: Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal a subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (PLoS ONE (2015) 8:2 (e56592))

UN SDGs

Access to Document

Other files and links

Cite this